The blood-brain barrier (BBB) 
environment, and has been demonstrated in AD patients by the abnormal presence of plasma proteins in the CSF or brain parenchyma, although some contrasting results exist
. Most recent studies have demonstrated a correlation between BBB leakage and advanced-stage AD [14] as well as medial temporal atrophy [13] . Animals receiving a peripheral A␤ injection [18] and transgenic AD mouse models [19] display increased BBB permeability. A␤ peptides have also been demonstrated to increase the permeability of non-human endothelial cell cultures [20, 21] . Changes in TJ organization may in part be responsible for the increased BBB permeability found in AD. Indeed, morphological alterations of BEC TJs, suggestive of a leaky BBB, have been observed in AD patients' brain biopsies [22] , and occludin downregulation is found in APP/PS1 transgenic mice [23] . A␤ 1-42 has also been noted to transiently decrease occludin expression and cause cldn-5 translocation from TJs in rat primary BECs [24] .
In this study, we have investigated the effects of A␤ on the permeability of human BECs in vitro. To do so, we used a wellestablished immortalized human BEC line, hCMEC/D3 cells [25] , to determine whether A␤ peptides could induce increased BEC permeability and to explore the signalling pathways that could mediate such changes. 
Materials and methods

Materials
Cell culture and treatments
hCMEC/D3 cells [25] were cultured on collagen-coated tissue culture plastic or collagen-coated glass cover slips (0.005% [w/v] Fig. 1 ).
Results
High concentrations of A␤ peptides reduce hCMEC/D3 cell viability
A␤ 1-40 increases hCMEC/D3 cell paracellular permeability
Increased BBB permeability has been demonstrated in AD patient brain tissue and in vivo AD models [13, 14, 19] [26] and in cerebrovascular deposits [27] . Fig. 4C and D) or cldn-5 ( Fig. 4A and B GSK-3␤) [29] did not prevent occludin down-regulation in hCMEC/D3 cells mediated by A␤ 1-40 (Suppl. Fig. 2) .
A␤ 1-40 specifically decreases levels of occludin at the protein and mRNA levels
MAPK family members ERK [30] , JNK [31] and p38MAPK [32] (Fig. 5A and B (Fig. 6B) [13, 14, [33] [34] [35] [36] . However, other studies have not confirmed this finding [15] [16] [17] . The most compelling evidence for increased BBB permeability in AD patients was provided by Zipser et al. [14] , who found that prothrombin leakage from the blood into the CNS was significant in advanced-stage AD. In addition, increased cerebrospinal fluid levels of albumin are associated with medial temporal atrophy as assessed by MRI measurements in AD patients [13] . A␤ could play a central role in mediating increased BBB permeability. Indeed, Tg2576 mice, which harbour the human Swedish mutation of APP, display increased BBB permeability after 4 months of age, prior to plaque deposition and disease onset, and these effects can be reversed via A␤ peptide immunization [19, 37] . [18] . In vitro endothelial cells of non-human origin also display increased permeability after A␤ treatment [20, 21] . In the present study, A␤ 1-40 was added to the luminal compartment, which corresponds to the blood side in vivo. Strazielle [41] or Xenopus embryo cells [42] results in increased paracellular permeability. In addition, occludin down-regulation and increased permeability has been observed in models of inflammatory pain [43] and oxidative stress [44] , and CNS disorders associated with BBB breakdown such as multiple sclerosis [45] . Here [7, [51] [52] [53] and astrocytic end feet swelling [54] and microglia activation [51] have been observed in AD tissue sections. IL-1␤, TNF-␣ and IL-6 levels are found increased in the CSF or serum of AD patients [55] and cytokines can induce a leaky TJ in vitro [56] [57] [58] [59] [65] . A␤ in this study was found to activate the 46-kD JNK isoform, which in some studies was found to correspond to JNK1 [65] . Regardless of the isoform, JNK inhibition protects SH-SY5Y neuroblastoma, rat cortical neurons and PC12 arrhenoblastoma cells from A␤-induced apoptosis in vitro [66] [67] [68] . A further interesting study has demonstrated that JNK inhibition can prevent H2O2-induced ␥-secretase-mediated APP cleavage and A␤ production in SH-SY5Y cells [69] . The 
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Fig. 4 The expression of TJ proteins by hCMEC/D3 cells after 48 hrs of A␤ 1-40 incubation as assessed by immunocytochemistry. hCMEC/D3 cells were incubated with 5 M (A, C, E) sA␤ 1-40 or (B, D, F) A␤ 1-40 for 48 hrs, fixed in methanol and the expression of cldn-5 (A, B), ZO-1, (C, D) or occludin (E, F) visualized by fluorescence microscopy. Image shown is of one experiment representative of three. Scale bar ϭ 50 M.
brain endothelial occludin down-regulation in a p38MAPK-and JNK-dependent manner.
JNK and p38MAPK inhibition attenuates A␤ 1-40-induced increased paracellular hCMEC/D3 cell permeability
Since JNK and p38MAPK inhibitors all attenuated occludin downregulation mediated by A␤ 1-40, we investigated whether they could also prevent A␤ 1-40-increased hCMEC/D3 cell permeability (Fig. 7). A␤ 1-40 treatment increased the Pe values of hCMEC/D3 cells to 70-kD FITC-dextran by 70% compared with sA␤ 1-40-treated cells. Pre-incubation with SB203580, TAT-TI-JIP153-163 and SP600125 prevented this increase in brain endothelial permeability. However, it should be noted that preincubation with SB203580 slightly increased the Pe values for hCMEC/D3 cells when incubated with both sA␤ 1-40 and A␤ 1-40 (by 32% and 25% Ϯ 12.6, respectively, when expressed as a percentage of vehicle-pre-incubated sA␤ 1-40 controls). Our results show that JNK and p38MAPK inhibition can prevent A␤ 1-40-mediated increase in hCMEC/D3 permeability to 70-kD FITCdextran, most likely by preventing occludin down-regulation.
Discussion
In this study, we initially determined the cytotoxicity of A␤ peptides to hCMEC/D3 cells. We then selected non-cytotoxic concentrations to further investigate specific A␤ effects on BBB permeability, rather than A␤-induced gross permeability changes due to BEC death. The lowest dose of A␤ 1-40 or A␤ 1-42 to elicit cytotoxic effects to human BECs after 48 hrs of incubation was, in both cases, 10 M.
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Increased CSF/plasma protein ratio of albumin and IgG has been noted in AD patients, suggestive of a leaky BBB
Further evidence comes from studies showing that intravascular jugular vein injections of A␤ 1-40 can induce a leaky BBB in rats
